Minute malignant islet cell tumor of the pancreas: report of a case

K Soda1, S Yamada, T Yamanaka

  • 1Department of Surgery, Omiya Medical Center, Jichi Medical School, Saitama, Japan.

Surgery Today
|January 1, 1995
PubMed

Insights

A tiny malignant islet cell tumor was found in a 73-year-old man. Endoscopic and intraoperative ultrasonography were crucial for diagnosis and surgical planning when other imaging failed.

Area of Science:

  • Gastroenterology and Hepatology
  • Surgical Oncology
  • Diagnostic Imaging

Background:

  • Islet cell tumors (neuroendocrine tumors) can be challenging to diagnose due to their small size and varied presentation.
  • Accurate localization and characterization are critical for appropriate surgical management.
  • Advanced imaging modalities play a key role in the diagnostic workup of pancreatic lesions.

Observation:

  • A 73-year-old Japanese man presented with gastric cancer, incidentally found to have a 7 mm hypoechoic pancreatic head mass on preoperative ultrasonography (US).
  • Standard imaging techniques including endoscopic retrograde pancreatography, angiography, CT, and MRI were inconclusive for tumor characterization and localization.
  • Endoscopic US and intraoperative US provided definitive visualization of the minute pancreatic mass.

Findings:

  • Intraoperative fine-needle aspiration cytology confirmed an islet cell tumor but was insufficient for malignancy grading.
  • Histologic examination of the enucleated tumor established the diagnosis and grade of malignancy.
  • The combined use of multiple imaging modalities, particularly US, was essential for successful diagnosis and surgical planning.

Implications:

  • This case highlights the diagnostic utility of endoscopic and intraoperative ultrasonography for small, elusive pancreatic islet cell tumors.
  • Accurate preoperative diagnosis and grading are vital for determining the optimal surgical approach, potentially avoiding more extensive resections.
  • The findings underscore the importance of a multimodal imaging strategy in managing pancreatic neuroendocrine tumors.